A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. [electronic resource]
Producer: 20050125Description: 624-31 p. digitalISSN:- 0090-8258
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Cystadenocarcinoma, Serous -- drug therapy
- Docetaxel
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Fallopian Tube Neoplasms -- drug therapy
- Female
- Humans
- Middle Aged
- Organoplatinum Compounds -- therapeutic use
- Ovarian Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.